March 20, 2022
Article
Test your neurology knowledge with NeurologyLive®'s weekly quiz series, featuring questions on a variety of clinical and historical neurology topics. This week's topic is optic neuritis and neuromyelitis optica spectrum disorder (NMOSD).
March 18, 2022
Article
Future research is required to include EEG analyses of neurodiverse patient populations.
March 16, 2022
Article
Updates from the open-label, delayed-start period of the pivotal 2-part MOXIe trial (NCT02255435) support previous positive primary end points findings from part 2 of the study.
March 15, 2022
Article
Investigators compared the effect of cognitive behavior therapy for insomnia alone, continuous positive airway pressure alone, and combined treatment.
March 15, 2022
Article
Data may be useful when analyzing disease progression and treatment efficacy in future facioscapulohumeral muscular dystrophy clinical trials.
March 15, 2022
Article
The treatment was well tolerated at 48 weeks in patients with DMD with a confirmed mutation amenable to exon 45 skipping.
March 13, 2022
Article
Speaking on his own presentation on economic burden in MS, Bruce Bebo, PhD, further shared his thoughts on areas of unmet need and the potential relationship of Epstein-Barr virus and MS.
March 13, 2022
Article
Test your neurology knowledge with NeurologyLive®'s weekly quiz series, featuring questions on a variety of clinical and historical neurology topics. This week's topic is sleep disorders.
March 12, 2022
Article
A systematic literature review of randomized controlled trials in neuromyelitis optica spectrum disorder was performed, with 7 studies identified and 2 used in analyses.
March 11, 2022
Article
Investigators noted the long-term cost-effectiveness and safety of this approach, as it does not require the regular use of disease-modifying therapies.
ALS-Related Biomarkers Remain Unchanged With PrimeC Combination Treatment
Awareness of Botulinum Toxins in the Movement Disorder Landscape: Laxman Bahroo, DO
Pioneering Care for Autoimmune Disorders Through Research and Results: The Mayo Clinic Way
NeuroVoices: Heidi Schambra, MD, on Expanding Capabilities of Stroke Rehabilitation With the PrimSeq Digital Tool